Operating Margin

The spirits giant faces a steep sales decline and a massive write-down, pivoting to premium brands and operational fixes amid an industry-wide hangover.

While many cannabis firms struggle, Greenway Greenhouse reports a 40% revenue jump, expanding margins, and its fifth straight quarter of positive EBITDA.

Appliance giant Groupe SEB faces a 25% profit drop, launching a massive AI-driven savings plan. Can it navigate global headwinds and job cuts?

Amid retail uncertainty, Gap Inc. raises its quarterly dividend by 6%, a move backed by strong financials and a bullish Wall Street outlook.

The healthcare specialist reported a staggering 2025 net loss due to a write-down, but projects 30% revenue growth fueled by new contracts.

Heritage Insurance projects a stunning full-year return on equity over 45%, setting the stage for a blockbuster earnings report on March 9.

Navitas Semiconductor accepts short-term losses for a future in AI data centers and energy, signaling a major shift in the power electronics landscape.

The tech firm announced progress on a major health contract, but with its stock near all-time lows, can this deal deliver a much-needed turnaround?

Hyperlink InfoSystem unveils AI agents promising to slash operational costs by up to 90%, signaling a major shift in workforce and business strategy.

The bioprocessing leader posted robust 2025 earnings, outperforming the market with strategic innovation and a major expansion into Asian markets.

Cell and gene therapy manufacturer OXB posts a dramatic turnaround to profitability, with surging revenues and an ambitious forecast for the coming years.

The powertrain giant crushed market expectations with a 29% revenue surge in 2025, fueled by heavy-duty engines, while eyeing a global and green future.

With a record $1.2B order backlog and a bullish 2026 forecast, the specialty vehicle maker also announces a major leadership shift to drive its next growth phase.

Forvia reports a €2.1B net loss but shows improved operations and cash flow. Is this strategic pain a necessary step toward long-term gain?

Beam Therapeutics is set to announce its 2025 financial results and a new liver-targeted therapy, a key moment for its base editing platform and investors.

As Flex heads to a key investor conference, a look at its record financials and pivotal role in building the high-stakes infrastructure for the AI era.

Satellogic launches its Aleph Observer service, shifting the satellite industry from ad-hoc snapshots to persistent, large-scale global monitoring.

With key investor conferences looming, Phathom Pharmaceuticals is set to showcase strong VOQUEZNA sales and a clear path to 2026 profitability.

Vantage Towers and Gridle partner to transform mobile sites into smart energy hubs, boosting resilience, profits, and sustainability. Here's how.

With its stock under pressure despite strong results, Box will use a key conference to prove its AI-powered content platform is the future of enterprise work.